Literature DB >> 10337015

Investigation of the expression of IL-1beta converting enzyme and apoptosis in normal and inflammatory bowel disease (IBD) mucosal macrophages.

M E McAlindon1, A Galvin, B McKaig, T Gray, H F Sewell, Y R Mahida.   

Abstract

Activated mucosal macrophages are derived from circulating monocytes and appear to play a major role in the pathogenesis of IBD. We have recently shown that IBD, but not normal, mucosal macrophages express the active form of IL-1beta converting enzyme (ICE) and are therefore capable of releasing mature IL-1beta. ICE expression by other mucosal cell types is unknown. Active ICE expression has also been implicated in apoptosis. The aim of this study was to investigate ICE expression (using an antibody that recognizes both active and precursor forms) in normal and IBD mucosa and to determine whether ICE-expressing macrophages are undergoing apoptosis. Normal and active IBD mucosal cells, in tissue sections and after isolation, were studied by immunohistochemistry and flow cytometry. In the mucosa, macrophages were the predominant ICE-expressing cell type. In contrast to normal, most IBD mucosal macrophages expressed ICE. Of IBD colonic macrophages 11.8 +/- 3.2%, and of normal colonic macrophages 6.6 +/- 0.6% expressed Apo2.7, a marker for apoptotic cells. Similar data were obtained when annexin V was used to identify cells undergoing apoptosis. DNA fluorescence flow cytometric analysis of normal and IBD lamina propria cells showed the presence of only small hypodiploid DNA peaks. We conclude that in the human intestinal mucosa, macrophages are the predominant ICE-expressing cell type. Expression of the active form of ICE and macrophage apoptosis are not interdependent. One mechanism of loss of resident macrophages from normal mucosa and of recruited macrophages from IBD mucosa is by apoptosis.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10337015      PMCID: PMC1905291          DOI: 10.1046/j.1365-2249.1999.00884.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  43 in total

1.  Increased macrophage subset in inflammatory bowel disease: apparent recruitment from peripheral blood monocytes.

Authors:  J Rugtveit; P Brandtzaeg; T S Halstensen; O Fausa; H Scott
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

Review 2.  The interleukin-1 family: 10 years of discovery.

Authors:  C A Dinarello
Journal:  FASEB J       Date:  1994-12       Impact factor: 5.191

3.  Attenuation of colitis in the cotton-top tamarin by anti-alpha 4 integrin monoclonal antibody.

Authors:  D K Podolsky; R Lobb; N King; C D Benjamin; B Pepinsky; P Sehgal; M deBeaumont
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

4.  Structure and mechanism of interleukin-1 beta converting enzyme.

Authors:  K P Wilson; J A Black; J A Thomson; E E Kim; J P Griffith; M A Navia; M A Murcko; S P Chambers; R A Aldape; S A Raybuck
Journal:  Nature       Date:  1994-07-28       Impact factor: 49.962

5.  Impaired response of activated mononuclear phagocytes to interleukin 4 in inflammatory bowel disease.

Authors:  S Schreiber; T Heinig; U Panzer; R Reinking; A Bouchard; P D Stahl; A Raedler
Journal:  Gastroenterology       Date:  1995-01       Impact factor: 22.682

6.  Respiratory burst activity of intestinal macrophages in normal and inflammatory bowel disease.

Authors:  Y R Mahida; K C Wu; D P Jewell
Journal:  Gut       Date:  1989-10       Impact factor: 23.059

7.  Interleukin 1 is released by murine macrophages during apoptosis induced by Shigella flexneri.

Authors:  A Zychlinsky; C Fitting; J M Cavaillon; P J Sansonetti
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

8.  Localization of intestinal interleukin 1 activity and protein and gene expression to lamina propria cells.

Authors:  K R Youngman; P L Simon; G A West; F Cominelli; D Rachmilewitz; J S Klein; C Fiocchi
Journal:  Gastroenterology       Date:  1993-03       Impact factor: 22.682

9.  Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3.

Authors:  M Miura; H Zhu; R Rotello; E A Hartwieg; J Yuan
Journal:  Cell       Date:  1993-11-19       Impact factor: 41.582

10.  Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guérin.

Authors:  A Molloy; P Laochumroonvorapong; G Kaplan
Journal:  J Exp Med       Date:  1994-10-01       Impact factor: 14.307

View more
  3 in total

1.  IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis.

Authors:  Ken Sugimoto; Atsuhiro Ogawa; Emiko Mizoguchi; Yasuyo Shimomura; Akira Andoh; Atul K Bhan; Richard S Blumberg; Ramnik J Xavier; Atsushi Mizoguchi
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

2.  Salmonella-induced caspase-2 activation in macrophages: a novel mechanism in pathogen-mediated apoptosis.

Authors:  V Jesenberger; K J Procyk; J Yuan; S Reipert; M Baccarini
Journal:  J Exp Med       Date:  2000-10-02       Impact factor: 14.307

3.  Ketone body β-hydroxybutyrate ameliorates colitis by promoting M2 macrophage polarization through the STAT6-dependent signaling pathway.

Authors:  Chongyang Huang; Jun Wang; Hongbin Liu; Ruo Huang; Xinwen Yan; Mengyao Song; Gao Tan; Fachao Zhi
Journal:  BMC Med       Date:  2022-04-15       Impact factor: 11.150

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.